Paper39690180
ITGA3 promotes pancreatic cancer progression through HIF1α- and c-Myc-driven glycolysis in a collagen I-dependent autocrine manner.
Li R and 9 others. Cancer Gene Ther, 2025. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. ITGA3 promotes pancreatic cancer progression through HIF1α- and c-Myc-driven glycolysis in a collagen I-dependent autocrine manner. Papers, record 39690180. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39690180
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- ITGA3 promotes pancreatic cancer progression through HIF1α- and c-Myc-driven glycolysis in a collagen I-dependent autocrine manner.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pancreatic Neoplasms | Major topic |
| Hypoxia-Inducible Factor 1, alpha Subunit | Major topic |
| Proto-Oncogene Proteins c-myc | Major topic |
| Integrin alpha3 | Major topic |
| Collagen Type I | Major topic |
| Humans | |
| Glycolysis | |
| Mice | |
| Animals | |
| Disease Progression | |
| Autocrine Communication | |
| Cell Line, Tumor | |
| Male | |
| Female | |
| Signal Transduction | |
| Cell Proliferation | |
| Gene Expression Regulation, Neoplastic |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| BK20210143 | Natural Science Foundation of Jiangsu Province (Jiangsu Provincial Natural Science Foundation) | PubMed | ||
| 82103105 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35868307 | Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer. | Cancer Cell | 2022 | https://conductscience.org/library/papers/35868307 | PubMed |
| 2 | 31737570 | Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches. | Front Oncol | 2019 | https://conductscience.org/library/papers/31737570 | PubMed |
| 3 | 8286197 | Human ductal adenocarcinomas of the pancreas express extracellular matrix proteins. | Br J Cancer | 1994 | https://conductscience.org/library/papers/8286197 | PubMed |
| 4 | 36843258 | Integrin α3 Mediates Stemness and Invasion of Glioblastoma by Regulating POU3F2. | Curr Protein Pept Sci | 2023 | https://conductscience.org/library/papers/36843258 | PubMed |
| 5 | 36271029 | Integrin regulation by tissue factor promotes cancer stemness and metastatic dissemination in breast cancer. | Oncogene | 2022 | https://conductscience.org/library/papers/36271029 | PubMed |
| 6 | 34108040 | CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/34108040 | PubMed |
| 7 | 34836938 | Reciprocal regulation of LOXL2 and HIF1α drives the Warburg effect to support pancreatic cancer aggressiveness. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/34836938 | PubMed |
| 8 | 39511266 | Elevated ITGA3 expression serves as a novel prognostic biomarker and regulates tumor progression in cervical cancer. | Sci Rep | 2024 | https://conductscience.org/library/papers/39511266 | PubMed |
| 9 | 30704479 | Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis. | Mol Cancer | 2019 | https://conductscience.org/library/papers/30704479 | PubMed |
| 10 | 37756163 | Microenvironmental stiffness induces metabolic reprogramming in glioblastoma. | Cell Rep | 2023 | https://conductscience.org/library/papers/37756163 | PubMed |
| 11 | 27680681 | α3β1 Integrin Suppresses Prostate Cancer Metastasis via Regulation of the Hippo Pathway. | Cancer Res | 2016 | https://conductscience.org/library/papers/27680681 | PubMed |
| 12 | 35597804 | Integrin α3/α6 and αV are implicated in ADAM15-activated FAK and EGFR signalling pathway individually and promote non-small-cell lung cancer progression. | Cell Death Dis | 2022 | https://conductscience.org/library/papers/35597804 | PubMed |
| 13 | 32953510 | High integrin α3 expression is associated with poor prognosis in patients with non-small cell lung cancer. | Transl Lung Cancer Res | 2020 | https://conductscience.org/library/papers/32953510 | PubMed |
| 14 | 30262472 | Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. | Science | 2018 | https://conductscience.org/library/papers/30262472 | PubMed |
| 15 | 31711924 | ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells. | Gastroenterology | 2020 | https://conductscience.org/library/papers/31711924 | PubMed |
| 16 | 31982456 | PGC1α suppresses kidney cancer progression by inhibiting collagen-induced SNAIL expression. | Matrix Biol | 2020 | https://conductscience.org/library/papers/31982456 | PubMed |
| 17 | 30889378 | Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance. | Cancer Cell | 2019 | https://conductscience.org/library/papers/30889378 | PubMed |
| 18 | 31987909 | ITGA3 interacts with VASP to regulate stemness and epithelial-mesenchymal transition of breast cancer cells. | Gene | 2020 | https://conductscience.org/library/papers/31987909 | PubMed |
| 19 | 36995683 | Induction of promyelocytic leukemia zinc finger protein by miR-200c-3p restores sensitivity to anti-androgen therapy in androgen-refractory prostate cancer and inhibits the cancer progression via down-regulation of integrin α3β4. | Cell Oncol (Dordr) | 2023 | https://conductscience.org/library/papers/36995683 | PubMed |
| 20 | 36375776 | Tumor and stroma COL8A1 secretion induces autocrine and paracrine progression signaling in pancreatic ductal adenocarcinoma. | Matrix Biol | 2022 | https://conductscience.org/library/papers/36375776 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42813234 | Fuelling repair: metabolic regulation of alveolar type 2 cell fate in lung regeneration and disease. | Dis Model Mech | 2026 | https://conductscience.org/library/papers/42813234 | PubMed |
| 42589604 | Myofibroblastic CAF and Malignant Ductal Cell Crosstalk Drives Epithelial-Mesenchymal Transition and Progression in Pancreatic Ductal Adenocarcinoma via THBS2-SDC/Integrin Axes. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42589604 | PubMed |
| 42343400 | TMEM33 regulates the proliferation and migration of lung adenocarcinoma by promoting the PI3K/AKT/mTOR signaling pathway. | Cancer Cell Int | 2026 | https://conductscience.org/library/papers/42343400 | PubMed |
| 42240927 | Enhanced ITGA3 expression induced by helicobacter pylori infection facilitates gastric cancer progression via NF-κB and Smad4. | Mol Cell Biochem | 2026 | https://conductscience.org/library/papers/42240927 | PubMed |
| 42014675 | CDC6/THBS1 accelerates pancreatic cancer progression via AKT-mediated glycolytic reprogramming. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/42014675 | PubMed |
| 41881953 | CAFs-derived LAM332 promotes CTCs formation and survival via ITGA3 and contributes to the metastasis of pancreatic ductal adenocarcinoma. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41881953 | PubMed |
| 41731056 | ITGA8 suppresses proliferation and metastasis of lung adenocarcinoma through the inhibition of glycolysis. | Sci Rep | 2026 | https://conductscience.org/library/papers/41731056 | PubMed |
| 41727317 | Multi-scale systems toxicology defines a KLF5-centered adverse outcome pathway linking DEHP exposure to pancreatic cancer progression and signaling programs relevant to therapy tolerance. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/41727317 | PubMed |
| 41675331 | Mechanistic insights into hepatic metastasis of pancreatic cancer: molecular perspectives. | Transl Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/41675331 | PubMed |
| 41556263 | S3RL: Enhancing Spatial Single-Cell Transcriptomics With Separable Representation Learning. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41556263 | PubMed |
| 41504500 | Integrative multi-omics and radiogenomic profiling decodes NNK-related tumor remodeling and prognostic stratification in pancreatic cancer. | Int J Surg | 2026 | https://conductscience.org/library/papers/41504500 | PubMed |
| 41501279 | Antimetastatic effects of MRTX1133 KRAS G12D specific inhibitor in a liver metastatic model of pancreatic ductal adenocarcinoma. | Sci Rep | 2026 | https://conductscience.org/library/papers/41501279 | PubMed |
| 41286938 | The role of ITGA3 expression in predicting liver metastasis in patients with epithelial ovarian cancer. | BMC Med Genomics | 2025 | https://conductscience.org/library/papers/41286938 | PubMed |
| 41284206 | Epithelial membrane protein 1 drives hepatic stellate cell activation via the TLN1/FAK cascade in MASLD donor liver transplantation. | Mol Biomed | 2025 | https://conductscience.org/library/papers/41284206 | PubMed |
| 41249748 | Expression of ITGA3 in pan-cancer tissues and its relationship to prognosis and immune infiltration. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41249748 | PubMed |
| 41182080 | Targeting Interactions Between Siglec-10 and α3β1 Integrin Enhances Macrophage-Mediated Phagocytosis of Pancreatic Cancer. | Cancer Res | 2026 | https://conductscience.org/library/papers/41182080 | PubMed |
| 40722937 | Serine-Driven Metabolic Plasticity Drives Adaptive Resilience in Pancreatic Cancer Cells. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40722937 | PubMed |
| 40646168 | Machine learning-based construction of a programmed cell death-related model reveals prognosis and immune infiltration in pancreatic adenocarcinoma patients. | Sci Rep | 2025 | https://conductscience.org/library/papers/40646168 | PubMed |
| 40630951 | Reprogramming of glucose metabolism in pancreatic cancer: mechanisms, implications, and therapeutic perspectives. | Front Immunol | 2025 | https://conductscience.org/library/papers/40630951 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| HIF1A | 3091 | PubTator's text mining | https://conductscience.org/library/genes/3091 | NCBI Gene |
| ITGA3 | 3675 | PubTator's text mining | https://conductscience.org/library/genes/3675 | NCBI Gene |
| MTOR | 2475 | PubTator's text mining | https://conductscience.org/library/genes/2475 | NCBI Gene |
| MYC | 4609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
| PTK2 | 5747 | PubTator's text mining | https://conductscience.org/library/genes/5747 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39690180
GET https://conductscience.org/api/papers/v1/39690180/references?page=2